Refine
Is part of the Bibliography
- yes (76)
Year of publication
Document Type
- Journal article (72)
- Conference Proceeding (4)
Keywords
- Chirurgie (5)
- Langerhans-Inseln (4)
- Transplantation (4)
- HNSCC (3)
- Schwein (3)
- brain (3)
- head and neck cancer (3)
- Antikörper (2)
- Bauchspeicheldrüse (2)
- Biochemie (2)
- Cancer (2)
- HGF (2)
- Medizin (2)
- Met (2)
- Toxikologie (2)
- biodiversity (2)
- cancer (2)
- cancer metabolism (2)
- cytokines (2)
- genome-wide association (2)
- 1 (1)
- 2-Dioxetane (1)
- 3D modeling (1)
- 5-HTTLPR (1)
- AMPK (1)
- Agent (1)
- Alpha therapy (1)
- Apoptosis (1)
- Autoimmune diseases (1)
- Bartak (1)
- Bauspeicheldrüse (1)
- Benzefuran dioxetane (1)
- Benzefuran epoxide (1)
- Berger-Parker (1)
- Bone marrow transplantantation (1)
- Breast-tumors (1)
- Bullous pemphigoid (1)
- CD44 (1)
- CD74 (1)
- CML (1)
- COX-2 (1)
- Calcineurin-NFATsignaling (1)
- Ceramide (1)
- Compound 3k (1)
- Cone-beam CT (1)
- DASA-58 (1)
- DFNB68 (1)
- DNA adduct . Repair endonuclease (1)
- DNA barcoding (1)
- DNA damage (1)
- Expression (1)
- FPG protein (1)
- Factor receptor (1)
- First G-APD Cherenkov Telescope (1)
- Functional modules (1)
- Golgi (1)
- Graft-versus-leukemia (1)
- HLA class II (1)
- HLA peptidome (1)
- HUWE1 (1)
- Heterotransplantation (1)
- Hill's powers (1)
- Histologie (1)
- Image-guidance (1)
- Imaging Air Cherenkov Telescope (1)
- Immunoadsorption (1)
- Immunoapheresis (1)
- In-vivo (1)
- Inhibitor (1)
- Integrated network analysis (1)
- Inter-observer variability (1)
- Isolierung <Mikrobiologie> (1)
- Japanese population (1)
- Jurkat cells (1)
- Kollagenase (1)
- Krebs (1)
- LND (1)
- LNE (1)
- Lung cancer (1)
- MFM (1)
- MHC Klasse II (1)
- MIZ1 (1)
- MTCH2 (1)
- MYC (1)
- Malaise trap (1)
- Metabolic pathways (1)
- Metabolic profiles (1)
- Milnesium tardigradum (1)
- Mutagenicity (1)
- N-oleoyl serinol (1)
- NHX1 (1)
- NK cells (1)
- NaCl transport (1)
- Niere (1)
- Nude-mice (1)
- PD-L1 (1)
- PKM2 (1)
- Pakistan (1)
- RNA (1)
- Ratte (1)
- Regulatory-cells (1)
- Respiration correlated imaging (1)
- Rheumatoid arthritis (1)
- S1PR2 (1)
- SLC6A4 (1)
- SUMO2 (1)
- Salmonella Typhimurium (1)
- Salt Overly Sensitive pathway (1)
- Suppression (1)
- T cells (1)
- TIC disorders (1)
- TXNIP (1)
- Tissue (1)
- Townes (1)
- Transplantat (1)
- Trend test (1)
- Tumor-necrosis-factor (1)
- VAL66MET polymorphism (1)
- Virologie (1)
- Warburg effect (1)
- activation (1)
- adaption (1)
- adrenal cancer (1)
- adrenocortical carcinoma (1)
- adsorption (1)
- allogeneic hematopoietic stem cell transplantation (1)
- animal behaviour (1)
- animal experimentation (1)
- animal model (1)
- antidepressant (1)
- apoptosis (1)
- arbuscular mycorrhizal fungi (1)
- arteriovenous extracorporeal hemadsorption technique (1)
- arthropods (1)
- association (1)
- autism (1)
- autosomal recessive non-synstromic hearing loss (1)
- auxin (1)
- bcl-2 associated athanogene protein 3 (1)
- betaglycan (1)
- bipolar disorder (1)
- blood purification (1)
- bone regeneration (1)
- borates (1)
- brain metastasis (1)
- calcium phosphate cement (1)
- calcium signaling (1)
- candidate gene (1)
- carbon fiber reinforcement (1)
- cardiac hypertrophy (1)
- case report (1)
- chemical diversity (1)
- chronic myeloid leukemia (1)
- classification (1)
- cluster (1)
- colorectal cancer (1)
- common SNPS (1)
- complex diseases (1)
- consanguinity (1)
- conservation biology (1)
- coordination polymers (1)
- coreceptor (1)
- correlate (1)
- cytosolic pH (1)
- damage tolerant cement (1)
- database (1)
- developmental dyscalculia (1)
- diarrhea (1)
- digestive system (1)
- disability (1)
- disease (1)
- disorders (1)
- drug discovery (1)
- drug treatment (1)
- dyscalculia (1)
- dyslexia (1)
- early respiratory-failure (1)
- efficacy (1)
- endotoxin (1)
- enzyme activation (1)
- enzyme inhibitors (1)
- essential tremor (1)
- exome sequencing (1)
- expressed sequence tag (1)
- expression (1)
- expression signature (1)
- extracorporeal hemadsorption (1)
- extracorporeal techniques in hemadsorption therapy (1)
- family (1)
- fiber–matrix interaction (1)
- gene expression (1)
- genetic diagnosis (1)
- genetics (1)
- genome-wide association study (1)
- genome-wide linkage analysis (1)
- genomic imaging (1)
- genotype (1)
- gilles (1)
- glycolysis (1)
- glycoprotein (1)
- growth factor beta (1)
- guided bone regeneration (1)
- halophyte (1)
- hearing impairment (1)
- hearing loss (1)
- helimagnets (1)
- identification (1)
- immune response (1)
- immune therapy (1)
- immunosorbents (1)
- inelastic neutron scattering (1)
- insect communities (1)
- insect monitoring (1)
- interface control (1)
- intraosseous (1)
- invasive species (1)
- ionic liquids (1)
- islets of Langerhans (1)
- kidney (1)
- lanthanides (1)
- leaf response (1)
- leishmania major (1)
- ligand binding (1)
- long-term monitoring (1)
- luminescence (1)
- lymph node dissection (1)
- lymph nodes (1)
- lymphadenectomy (1)
- lymphoma (1)
- major depressive disorder (1)
- mandible (1)
- markers (1)
- mathematics (1)
- melt electrospinning writing (1)
- messenger RNA (1)
- meta-analysis (1)
- metabarcoding (1)
- metastasis (1)
- missing heritability (1)
- mixed hearing loss (1)
- modules (1)
- molecular diversity (1)
- monitoring (1)
- mood disorder (1)
- mouse models (1)
- movement disorders (1)
- mucosal inflammation (1)
- multiparametric magnetic resonance imaging (1)
- muscular-dystrophy (1)
- mutagenesis (1)
- myasthenia gravis (1)
- myopathy (1)
- neovascularization, physiologic (1)
- neuropsychiatric disorders (1)
- neurotrophic factor gene (1)
- next generation sequencing (1)
- osmotic effects (1)
- parasitic diseases (1)
- permeation and transport (1)
- pest species (1)
- pharmacogenetics (1)
- pharmacology (1)
- phase conversion (1)
- physics (1)
- plant diversity (1)
- plantago lanceolata (1)
- polar ion transport (1)
- polycaprolactone (1)
- polymerization (1)
- polyneuropathy (1)
- prelevance (1)
- protein aggregation (1)
- protein familiy (1)
- protein-interaction networks (1)
- proteins (1)
- pseudocarcinomatous hyperplasia (1)
- quality-control (1)
- quantitative trait (1)
- quinoa (1)
- rat (1)
- receptor type III (1)
- review (1)
- salt stress (1)
- salt tolerance (1)
- scaffold (1)
- secretion (1)
- septic shock (1)
- sequence variations (1)
- set (1)
- shannon index (1)
- silicon photo multiplier (1)
- simpson's index (1)
- skeletal myopathy (1)
- spin waves (1)
- stability (1)
- stalk cell (1)
- stem cell transplantation (1)
- sulcal morphology (1)
- superfamily (1)
- survival (1)
- swine (1)
- tardigrada (1)
- targeted (1)
- thymic carcinoma (1)
- thymoma (1)
- thymus (1)
- tissue engineering (1)
- tolerability (1)
- tool (1)
- transcriptome (1)
- translational medical research (1)
- trap selectivity (1)
- treatment response (1)
- tremor (1)
- tumor infiltrating lymphocytes (1)
- tumor-suppressor gene (1)
- tyrosine kinase inhibitors (1)
- ubiquitination (1)
- very high energy gamma rays (1)
- whole exome sequencing (1)
- xenogenic transplantation (1)
- α-tricalcium phosphate (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (25)
- Theodor-Boveri-Institut für Biowissenschaften (16)
- Institut für Virologie und Immunbiologie (5)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (5)
- Pathologisches Institut (4)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (3)
- Institut für Humangenetik (3)
- Institut für Molekulare Infektionsbiologie (3)
- Julius-von-Sachs-Institut für Biowissenschaften (3)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (3)
Sonstige beteiligte Institutionen
The current study aims to extend the material platform for anisotropically structured calcium phosphates to low-temperature phases such as calcium-deficient hydroxyapatite (CDHA) or the secondary phosphates monetite and brushite. This is achieved by the phase conversion of highly porous α-tricalcium phosphate (α-TCP) scaffolds fabricated by ice-templating into the aforementioned phases by hydrothermal treatment or incubation in phosphoric acid. Prior to these steps, α-TCP scaffolds are either sintered for 8 h at 1400 °C or remain in their original state. Both nonsintered and sintered α-TCP specimens are converted into CDHA by hydrothermal treatment, while a transformation into monetite and brushite is achieved by incubation in phosphoric acid. Hydrothermal treatment for 72 h at 175 °C increases the porosity in nonsintered samples from 85% to 88% and from 75% to 88% in the sintered ones. An increase in the specific surface area from (1.102 ± 0.005) to (9.17 ± 0.01) m2 g−1 and from (0.190 ± 0.004) to (2.809 ± 0.002) m2 g−1 due to the phase conversion is visible for both the nonsintered and sintered samples. Compressive strength of the nonsintered samples increases significantly from (0.76 ± 0.11) to (5.29 ± 0.94) MPa due to incubation in phosphoric acid.
Background: Extracorporeal hemadsorption eliminates proinflammatory mediators in critically ill patients with hyperinflammation. The use of a pumpless extracorporeal hemadsorption technique allows its early usage prior to organ failure and the need for an additional medical device. In our animal model, we investigated the feasibility of pumpless extracorporeal hemadsorption over a wide range of mean arterial pressures (MAP). Methods: An arteriovenous shunt between the femoral artery and femoral vein was established in eight pigs. The hemadsorption devices were inserted into the shunt circulation; four pigs received CytoSorb\(^®\) and four Oxiris\(^®\) hemadsorbers. Extracorporeal blood flow was measured in a range between mean arterial pressures of 45–85 mmHg. Mean arterial pressures were preset using intravenous infusions of noradrenaline, urapidil, or increased sedatives. Results: Extracorporeal blood flows remained well above the minimum flows recommended by the manufacturers throughout all MAP steps for both devices. Linear regression resulted in CytoSorb\(^®\) blood flow [mL/min] = 4.226 × MAP [mmHg] − 3.496 (R-square 0.8133) and Oxiris\(^®\) blood flow [mL/min] = 3.267 × MAP [mmHg] + 57.63 (R-square 0.8708), respectively. Conclusion: Arteriovenous pumpless extracorporeal hemadsorption resulted in sufficient blood flows through both the CytoSorb\(^®\) and Oxiris\(^®\) devices over a wide range of mean arterial blood pressures and is likely an intriguing therapeutic option in the early phase of septic shock or hyperinflammatory syndromes.
Tropical forest recovery is fundamental to addressing the intertwined climate and biodiversity loss crises. While regenerating trees sequester carbon relatively quickly, the pace of biodiversity recovery remains contentious. Here, we use bioacoustics and metabarcoding to measure forest recovery post-agriculture in a global biodiversity hotspot in Ecuador. We show that the community composition, and not species richness, of vocalizing vertebrates identified by experts reflects the restoration gradient. Two automated measures – an acoustic index model and a bird community composition derived from an independently developed Convolutional Neural Network - correlated well with restoration (adj-R² = 0.62 and 0.69, respectively). Importantly, both measures reflected composition of non-vocalizing nocturnal insects identified via metabarcoding. We show that such automated monitoring tools, based on new technologies, can effectively monitor the success of forest recovery, using robust and reproducible data.
Based on the strand‐like coordination polymer (CP) type \(^{1}\)\(_{∞}\)[Ln(BSB)\(_{3}\)(py)\(_{2}\)], [BSB]−=bis‐salicylatoborate anion, mixed Eu/Tb‐containing compounds of the constitution \(^{1}\)\(_{∞}\)[Eu\(_{x}\)Tb\(_{1-x}\)(BSB)\(_{3}\)(py)\(_{2}\)] were synthesised ionothermally for a phase width of (x=0.25–0.75) and characterized regarding structure and optical properties. Previously, known only for other lanthanides, the mixed 1D−Eu/Tb‐CPs show excellent options for statistic replacement of the Ln‐cations during synthesis yielding solid solutions. The products are highly luminescent, with the chromaticity being a direct function of the amount of the respective Ln‐ions. Corresponding to an overall addition of emission intensities, the green Tb\(^{3+}\) emission and the red Eu\(^{3+}\) emission allow for a chromaticity control that also includes yellow emission. Control of the luminescence colour renders them suitable examples of the versatility of statistic replacement of metal ions in coordination chemistry. In addition, crystallization of [EMIm]\(_{2}\)[YCl\(_{5}\)(py)] illuminates possible other products of the ionothermal reactions of [EMIm][BSB] with LnCl\(_{3}\) constituted by components not being part of the main CPs.
Head and neck squamous cell carcinoma (HNSCC) is a widespread disease with a low survival rate and a high risk of recurrence. Nowadays, immune checkpoint inhibitor (ICI) treatment is approved for HNSCC as a first-line treatment in recurrent and metastatic disease. ICI treatment yields a clear survival benefit, but overall response rates are still unsatisfactory. As shown in different cancer models, hepatocyte growth factor/mesenchymal–epithelial transition (HGF/Met) signaling contributes to an immunosuppressive microenvironment. Therefore, we investigated the relationship between HGF and programmed cell death protein 1 (PD-L1) expression in HNSCC cell lines. The preclinical data show a robust PD-L1 induction upon HGF stimulation. Further analysis revealed that the HGF-mediated upregulation of PD-L1 is MAP kinase-dependent. We then hypothesized that serum levels of HGF and soluble programmed cell death protein 1 (sPD-L1) could be potential markers of ICI treatment failure. Thus, we determined serum levels of these proteins in 20 HNSCC patients before ICI treatment and correlated them with treatment outcomes. Importantly, the clinical data showed a positive correlation of both serum proteins (HGF and sPD-L1) in HNSCC patient’s sera. Moreover, the serum concentration of sPD-L1 was significantly higher in ICI non-responsive patients. Our findings indicate a potential role for sPD-L1 as a prognostic marker for ICI treatment in HNSCC.
The enzyme pyruvate kinase M2 (PKM2) plays a major role in the switch of tumor cells from oxidative phosphorylation to aerobic glycolysis, one of the hallmarks of cancer. Different allosteric inhibitors or activators and several posttranslational modifications regulate its activity. Head and neck squamous cell carcinoma (HNSCC) is a common disease with a high rate of recurrence. To find out more about PKM2 and its modulation in HNSCC, we examined a panel of HNSCC cells using real-time cell metabolic analysis and Western blotting with an emphasis on phosphorylation variant Tyr105 and two reagents known to impair PKM2 activity. Our results show that in HNSCC, PKM2 is commonly phosphorylated at Tyrosine 105. Its levels depended on tyrosine kinase activity, emphasizing the importance of growth factors such as EGF (epidermal growth factor) on HNSCC metabolism. Furthermore, its correlation with the expression of CD44 indicates a role in cancer stemness. Cells generally reacted with higher glycolysis to PKM2 activator DASA-58 and lower glycolysis to PKM2 inhibitor Compound 3k, but some were more susceptible to activation and others to inhibition. Our findings emphasize the need to further investigate the role of PKM2 in HNSCC, as it could aid understanding and treatment of the disease.
The current molecular genetic diagnostic rates for hereditary hearing loss (HL) vary considerably according to the population background. Pakistan and other countries with high rates of consanguineous marriages have served as a unique resource for studying rare and novel forms of recessive HL. A combined exome sequencing, bioinformatics analysis, and gene mapping approach for 21 consanguineous Pakistani families revealed 13 pathogenic or likely pathogenic variants in the genes GJB2, MYO7A, FGF3, CDC14A, SLITRK6, CDH23, and MYO15A, with an overall resolve rate of 61.9%. GJB2 and MYO7A were the most frequently involved genes in this cohort. All the identified variants were either homozygous or compound heterozygous, with two of them not previously described in the literature (15.4%). Overall, seven missense variants (53.8%), three nonsense variants (23.1%), two frameshift variants (15.4%), and one splice-site variant (7.7%) were observed. Syndromic HL was identified in five (23.8%) of the 21 families studied. This study reflects the extreme genetic heterogeneity observed in HL and expands the spectrum of variants in deafness-associated genes.
Antidepressants are used to treat several psychiatric disorders; however, a large proportion of patients do not respond to their first antidepressant therapy and often experience adverse drug reactions (ADR). A common insertion–deletion polymorphism in the promoter region (5-HTTLPR) of the serotonin transporter (SLC6A4) gene has been frequently investigated for its association with antidepressant outcomes. Here, we performed a systematic review and meta-analysis to assess 5-HTTLPR associations with antidepressants: (1) response in psychiatric disorders other than major depressive disorder (MDD) and (2) tolerability across all psychiatric disorders. Literature searches were performed up to January 2021, yielding 82 studies that met inclusion criteria, and 16 of these studies were included in the meta-analyses. Carriers of the 5-HTTLPR LL or LS genotypes were more likely to respond to antidepressant therapy, compared to the SS carriers in the total and European ancestry-only study populations. Long (L) allele carriers taking selective serotonin reuptake inhibitors (SSRIs) reported fewer ADRs relative to short/short (SS) carriers. European L carriers taking SSRIs had lower ADR rates than S carriers. These results suggest the 5-HTTLPR polymorphism may serve as a marker for antidepressant outcomes in psychiatric disorders and may be particularly relevant to SSRI treatment among individuals of European descent.
Objectives
Micro-computed tomography (μ-CT) and histology, the current gold standard methods for assessing the formation of new bone and blood vessels, are invasive and/or destructive. With that in mind, a more conservative tool, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), was tested for its accuracy and reproducibility in monitoring neovascularization during bone regeneration. Additionally, the suitability of blood perfusion as a surrogate of the efficacy of osteoplastic materials was evaluated.
Materials and methods
Sixteen rabbits were used and equally divided into four groups, according to the time of euthanasia (2, 3, 4, and 6 weeks after surgery). The animals were submitted to two 8-mm craniotomies that were filled with blood or autogenous bone. Neovascularization was assessed in vivo through DCE-MRI, and bone regeneration, ex vivo, through μ-CT and histology.
Results
The defects could be consistently identified, and their blood perfusion measured through DCE-MRI, there being statistically significant differences within the blood clot group between 3 and 6 weeks (p = 0.029), and between the former and autogenous bone at six weeks (p = 0.017). Nonetheless, no significant correlations between DCE-MRI findings on neovascularization and μ-CT (r =−0.101, 95% CI [−0.445; 0.268]) or histology (r = 0.305, 95% CI [−0.133; 0.644]) findings on bone regeneration were observed.
Conclusions
These results support the hypothesis that DCE-MRI can be used to monitor neovascularization but contradict the premise that it could predict bone regeneration as well.
Auxin is a key regulator of plant growth and development, but the causal relationship between hormone transport and root responses remains unresolved. Here we describe auxin uptake, together with early steps in signaling, in Arabidopsis root hairs. Using intracellular microelectrodes we show membrane depolarization, in response to IAA in a concentration- and pH-dependent manner. This depolarization is strongly impaired in aux1 mutants, indicating that AUX1 is the major transporter for auxin uptake in root hairs. Local intracellular auxin application triggers Ca2+ signals that propagate as long-distance waves between root cells and modulate their auxin responses. AUX1-mediated IAA transport, as well as IAA- triggered calcium signals, are blocked by treatment with the SCFTIR1/AFB - inhibitor auxinole. Further, they are strongly reduced in the tir1afb2afb3 and the cngc14 mutant. Our study reveals that the AUX1 transporter, the SCFTIR1/AFB receptor and the CNGC14 Ca2+ channel, mediate fast auxin signaling in roots.